A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).

Clinical trial NCT00838357 · COMPLETED

Trial details

NCT number: NCT00838357
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma (Non-Hodgkin's Lymphoma)Hodgkin's Disease or Multiple Myeloma Front Line Mobilization Transplantation

Start date: 2008-09-01
Primary completion: 2010-11-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.